Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive
N/A
19 Years
N/A
19 Years
N/A
Open (Enrolling)
Both
Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer, Gastrointestinal Carcinoma, Pancreatic Carcinoma, Lung Cancer, Esophageal Carcinoma
Both
Endometrial Cancer, Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer, Gastrointestinal Carcinoma, Pancreatic Carcinoma, Lung Cancer, Esophageal Carcinoma
Trial Information
Narrow Band Imaging (NBI): A Novel Imaging Modality in Minimally Invasive
Inclusion Criteria:
- Patients must meet one (or more) of the following criteria:
- Preoperative diagnosis of ovarian, fallopian tube, or primary peritoneal carcinoma
(all stage, grade and histology)
- Preoperative diagnosis of grade III endometrial carcinoma (all stage, all histology)
- Preoperative diagnosis of uterine serous carcinoma (all stage, all grade)
- Preoperative diagnosis of clear cell endometrial carcinoma (all stage, all grade)
- Preoperative diagnosis of endometrial carcinosarcoma (all stage, all grade)
- Gastrointestinal carcinoma (all histology, stage and grade)
- Pancreatic carcinoma (all histology, stage and grade)
- Lung cancer (all histology, stage and grade)
- Esophageal carcinoma (all histology, stage and grade)
- Suspected or pathologically confirmed metastatic disease to the lung (all disease
primaries)
- Suspected or pathologically confirmed malignant pleural effusion (all disease
primaries)
Patients must meet all of the following criteria:
- Planned thorascopic robotic or laparoscopic surgical approach
- >18 years old
- Not pregnant
- Able to give consent Participation in other research protocols does not exclude a
patient from participation in this study.
Exclusion Criteria:
- None
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
Determine the feasibility of Narrow Band Imaging (NBI) at the time of thorascopic, laparoscopic or robotic surgery.
Outcome Time Frame:
1 year
Safety Issue:
No
Principal Investigator
Nadeem Abu-Rustum, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Memorial Sloan-Kettering Cancer Center
Authority:
United States: Institutional Review Board
Study ID:
10-180
NCT ID:
NCT01262040
Start Date:
December 2010
Completion Date:
December 2013
Related Keywords:
- Endometrial Cancer
- Fallopian Tube Cancer
- Ovarian Cancer
- Peritoneal Cancer
- Gastrointestinal Carcinoma
- Pancreatic Carcinoma
- Lung Cancer
- Esophageal Carcinoma
- NBI
- ENDOMETRIUM
- FALLOPIAN TUBE
- OVARY
- PERITONEUM
- Surgery
- Lung
- Pancreatic
- Esophageal
- thorascopic
- laparoscopic
- robotic
- 10-180
- Carcinoma
- Endometrial Neoplasms
- Esophageal Diseases
- Esophageal Neoplasms
- Lung Neoplasms
- Ovarian Neoplasms
- Pancreatic Neoplasms
- Rectal Neoplasms
- Duodenal Neoplasms
- Bile Duct Neoplasms
- Peritoneal Neoplasms
- Fallopian Tube Neoplasms
- Adenoma
Name | Location |
|---|---|
| Memorial Sloan-Kettering Cancer Center | New York, New York 10021 |
